Search results
26 sty 2001 · In a randomised, double blind, placebo controlled trial, between 1992 and 1996, 71 patients with acute reactive arthritis (ReA) triggered by a gastrointestinal or an urogenital infection were randomly assigned to receive ciprofloxacin or placebo twice daily for three months.
- Effect of a three month course of ciprofloxacin on the outcome of ...
Objective: To evaluate the effect of a three month course of...
- Effect of a three month course of ciprofloxacin on the outcome of ...
Analysis 4-7 years after the initial ReA suggests that a three month course of antibiotics in the acute phase may have a beneficial effect on the long term prognosis.
No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study.
Objective: To evaluate the effect of a three month course of ciprofloxacin on ReA. Methods: In a randomised, double blind, placebo controlled trial, between December 1992 and February 1996, 71 patients with acute ReA triggered by a gastrointestinal or a urogenital infection were randomly assigned to receive ciprofloxacin 500 mg or placebo twice ...
20 gru 2019 · Objectives: Identify the mechanism of action of ciprofloxacin. Summarize the types of infections and bacterial coverage of ciprofloxacin and where it would be effective in a target population. Recognize the potential adverse events associated with ciprofloxacin therapy.
This study revealed that the antibacterial activity of the formulation was maintained for 3 months at both temperatures (4 and 25°C) and CIP nanocrystals have excellent potential to treat infections caused by such microorganisms.
Ciprofloxacin, given as a three month course, had no advantage over placebo treatment. Eradication of the causative microbe appears logical, but short term antibiotic treatment has no beneficial effect on the outcome of ReA.
